Global Newcastle Disease Vaccine Market Insights, Forecast to 2029

Global Newcastle Disease Vaccine Market Insights, Forecast to 2029

Table of Contents
1 Study Coverage
1.1 Newcastle Disease Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global Newcastle Disease Vaccine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Live Vaccines
1.2.3 Killed Vaccines
1.3 Market by Application
1.3.1 Global Newcastle Disease Vaccine Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Chicken
1.3.3 Duck & Goose
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Newcastle Disease Vaccine Sales Estimates and Forecasts 2018-2029
2.2 Global Newcastle Disease Vaccine Revenue by Region
2.2.1 Global Newcastle Disease Vaccine Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Newcastle Disease Vaccine Revenue by Region (2018-2023)
2.2.3 Global Newcastle Disease Vaccine Revenue by Region (2024-2029)
2.2.4 Global Newcastle Disease Vaccine Revenue Market Share by Region (2018-2029)
2.3 Global Newcastle Disease Vaccine Sales Estimates and Forecasts 2018-2029
2.4 Global Newcastle Disease Vaccine Sales by Region
2.4.1 Global Newcastle Disease Vaccine Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Newcastle Disease Vaccine Sales by Region (2018-2023)
2.4.3 Global Newcastle Disease Vaccine Sales by Region (2024-2029)
2.4.4 Global Newcastle Disease Vaccine Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Newcastle Disease Vaccine Sales by Manufacturers
3.1.1 Global Newcastle Disease Vaccine Sales by Manufacturers (2018-2023)
3.1.2 Global Newcastle Disease Vaccine Sales Market Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Newcastle Disease Vaccine in 2022
3.2 Global Newcastle Disease Vaccine Revenue by Manufacturers
3.2.1 Global Newcastle Disease Vaccine Revenue by Manufacturers (2018-2023)
3.2.2 Global Newcastle Disease Vaccine Revenue Market Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by Newcastle Disease Vaccine Revenue in 2022
3.3 Global Key Players of Newcastle Disease Vaccine, Industry Ranking, 2021 VS 2022 VS 2023
3.4 Global Newcastle Disease Vaccine Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Newcastle Disease Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Newcastle Disease Vaccine, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Newcastle Disease Vaccine, Product Offered and Application
3.8 Global Key Manufacturers of Newcastle Disease Vaccine, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Newcastle Disease Vaccine Sales by Type
4.1.1 Global Newcastle Disease Vaccine Historical Sales by Type (2018-2023)
4.1.2 Global Newcastle Disease Vaccine Forecasted Sales by Type (2024-2029)
4.1.3 Global Newcastle Disease Vaccine Sales Market Share by Type (2018-2029)
4.2 Global Newcastle Disease Vaccine Revenue by Type
4.2.1 Global Newcastle Disease Vaccine Historical Revenue by Type (2018-2023)
4.2.2 Global Newcastle Disease Vaccine Forecasted Revenue by Type (2024-2029)
4.2.3 Global Newcastle Disease Vaccine Revenue Market Share by Type (2018-2029)
4.3 Global Newcastle Disease Vaccine Price by Type
4.3.1 Global Newcastle Disease Vaccine Price by Type (2018-2023)
4.3.2 Global Newcastle Disease Vaccine Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Newcastle Disease Vaccine Sales by Application
5.1.1 Global Newcastle Disease Vaccine Historical Sales by Application (2018-2023)
5.1.2 Global Newcastle Disease Vaccine Forecasted Sales by Application (2024-2029)
5.1.3 Global Newcastle Disease Vaccine Sales Market Share by Application (2018-2029)
5.2 Global Newcastle Disease Vaccine Revenue by Application
5.2.1 Global Newcastle Disease Vaccine Historical Revenue by Application (2018-2023)
5.2.2 Global Newcastle Disease Vaccine Forecasted Revenue by Application (2024-2029)
5.2.3 Global Newcastle Disease Vaccine Revenue Market Share by Application (2018-2029)
5.3 Global Newcastle Disease Vaccine Price by Application
5.3.1 Global Newcastle Disease Vaccine Price by Application (2018-2023)
5.3.2 Global Newcastle Disease Vaccine Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Newcastle Disease Vaccine Market Size by Type
6.1.1 US & Canada Newcastle Disease Vaccine Sales by Type (2018-2029)
6.1.2 US & Canada Newcastle Disease Vaccine Revenue by Type (2018-2029)
6.2 US & Canada Newcastle Disease Vaccine Market Size by Application
6.2.1 US & Canada Newcastle Disease Vaccine Sales by Application (2018-2029)
6.2.2 US & Canada Newcastle Disease Vaccine Revenue by Application (2018-2029)
6.3 US & Canada Newcastle Disease Vaccine Market Size by Country
6.3.1 US & Canada Newcastle Disease Vaccine Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Newcastle Disease Vaccine Sales by Country (2018-2029)
6.3.3 US & Canada Newcastle Disease Vaccine Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Newcastle Disease Vaccine Market Size by Type
7.1.1 Europe Newcastle Disease Vaccine Sales by Type (2018-2029)
7.1.2 Europe Newcastle Disease Vaccine Revenue by Type (2018-2029)
7.2 Europe Newcastle Disease Vaccine Market Size by Application
7.2.1 Europe Newcastle Disease Vaccine Sales by Application (2018-2029)
7.2.2 Europe Newcastle Disease Vaccine Revenue by Application (2018-2029)
7.3 Europe Newcastle Disease Vaccine Market Size by Country
7.3.1 Europe Newcastle Disease Vaccine Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Newcastle Disease Vaccine Sales by Country (2018-2029)
7.3.3 Europe Newcastle Disease Vaccine Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Newcastle Disease Vaccine Market Size
8.1.1 China Newcastle Disease Vaccine Sales (2018-2029)
8.1.2 China Newcastle Disease Vaccine Revenue (2018-2029)
8.2 China Newcastle Disease Vaccine Market Size by Application
8.2.1 China Newcastle Disease Vaccine Sales by Application (2018-2029)
8.2.2 China Newcastle Disease Vaccine Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Newcastle Disease Vaccine Market Size by Type
9.1.1 Asia Newcastle Disease Vaccine Sales by Type (2018-2029)
9.1.2 Asia Newcastle Disease Vaccine Revenue by Type (2018-2029)
9.2 Asia Newcastle Disease Vaccine Market Size by Application
9.2.1 Asia Newcastle Disease Vaccine Sales by Application (2018-2029)
9.2.2 Asia Newcastle Disease Vaccine Revenue by Application (2018-2029)
9.3 Asia Newcastle Disease Vaccine Sales by Region
9.3.1 Asia Newcastle Disease Vaccine Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Newcastle Disease Vaccine Revenue by Region (2018-2029)
9.3.3 Asia Newcastle Disease Vaccine Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Newcastle Disease Vaccine Market Size by Type
10.1.1 Middle East, Africa and Latin America Newcastle Disease Vaccine Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Newcastle Disease Vaccine Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Newcastle Disease Vaccine Market Size by Application
10.2.1 Middle East, Africa and Latin America Newcastle Disease Vaccine Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Newcastle Disease Vaccine Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Newcastle Disease Vaccine Sales by Country
10.3.1 Middle East, Africa and Latin America Newcastle Disease Vaccine Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Newcastle Disease Vaccine Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Newcastle Disease Vaccine Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Merial
11.1.1 Merial Company Information
11.1.2 Merial Overview
11.1.3 Merial Newcastle Disease Vaccine Sales, Price, Revenue and Gross Margin (2018-2023)
11.1.4 Merial Newcastle Disease Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Merial Recent Developments
11.2 CEVA
11.2.1 CEVA Company Information
11.2.2 CEVA Overview
11.2.3 CEVA Newcastle Disease Vaccine Sales, Price, Revenue and Gross Margin (2018-2023)
11.2.4 CEVA Newcastle Disease Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 CEVA Recent Developments
11.3 QYH Biotech
11.3.1 QYH Biotech Company Information
11.3.2 QYH Biotech Overview
11.3.3 QYH Biotech Newcastle Disease Vaccine Sales, Price, Revenue and Gross Margin (2018-2023)
11.3.4 QYH Biotech Newcastle Disease Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 QYH Biotech Recent Developments
11.4 Ringpu Biology
11.4.1 Ringpu Biology Company Information
11.4.2 Ringpu Biology Overview
11.4.3 Ringpu Biology Newcastle Disease Vaccine Sales, Price, Revenue and Gross Margin (2018-2023)
11.4.4 Ringpu Biology Newcastle Disease Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Ringpu Biology Recent Developments
11.5 Yebio
11.5.1 Yebio Company Information
11.5.2 Yebio Overview
11.5.3 Yebio Newcastle Disease Vaccine Sales, Price, Revenue and Gross Margin (2018-2023)
11.5.4 Yebio Newcastle Disease Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Yebio Recent Developments
11.6 Harbin Veterinary Research Institute
11.6.1 Harbin Veterinary Research Institute Company Information
11.6.2 Harbin Veterinary Research Institute Overview
11.6.3 Harbin Veterinary Research Institute Newcastle Disease Vaccine Sales, Price, Revenue and Gross Margin (2018-2023)
11.6.4 Harbin Veterinary Research Institute Newcastle Disease Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Harbin Veterinary Research Institute Recent Developments
11.7 Merck Animal Health
11.7.1 Merck Animal Health Company Information
11.7.2 Merck Animal Health Overview
11.7.3 Merck Animal Health Newcastle Disease Vaccine Sales, Price, Revenue and Gross Margin (2018-2023)
11.7.4 Merck Animal Health Newcastle Disease Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Merck Animal Health Recent Developments
11.8 DHN
11.8.1 DHN Company Information
11.8.2 DHN Overview
11.8.3 DHN Newcastle Disease Vaccine Sales, Price, Revenue and Gross Margin (2018-2023)
11.8.4 DHN Newcastle Disease Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 DHN Recent Developments
11.9 Zoetis
11.9.1 Zoetis Company Information
11.9.2 Zoetis Overview
11.9.3 Zoetis Newcastle Disease Vaccine Sales, Price, Revenue and Gross Margin (2018-2023)
11.9.4 Zoetis Newcastle Disease Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Zoetis Recent Developments
11.10 ChengDu Tecbond
11.10.1 ChengDu Tecbond Company Information
11.10.2 ChengDu Tecbond Overview
11.10.3 ChengDu Tecbond Newcastle Disease Vaccine Sales, Price, Revenue and Gross Margin (2018-2023)
11.10.4 ChengDu Tecbond Newcastle Disease Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 ChengDu Tecbond Recent Developments
11.11 Elanco (Lohmann)
11.11.1 Elanco (Lohmann) Company Information
11.11.2 Elanco (Lohmann) Overview
11.11.3 Elanco (Lohmann) Newcastle Disease Vaccine Sales, Price, Revenue and Gross Margin (2018-2023)
11.11.4 Elanco (Lohmann) Newcastle Disease Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Elanco (Lohmann) Recent Developments
11.12 FATRO
11.12.1 FATRO Company Information
11.12.2 FATRO Overview
11.12.3 FATRO Newcastle Disease Vaccine Sales, Price, Revenue and Gross Margin (2018-2023)
11.12.4 FATRO Newcastle Disease Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 FATRO Recent Developments
11.13 CAVAC
11.13.1 CAVAC Company Information
11.13.2 CAVAC Overview
11.13.3 CAVAC Newcastle Disease Vaccine Sales, Price, Revenue and Gross Margin (2018-2023)
11.13.4 CAVAC Newcastle Disease Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 CAVAC Recent Developments
11.14 Vaksindo
11.14.1 Vaksindo Company Information
11.14.2 Vaksindo Overview
11.14.3 Vaksindo Newcastle Disease Vaccine Sales, Price, Revenue and Gross Margin (2018-2023)
11.14.4 Vaksindo Newcastle Disease Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Vaksindo Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Newcastle Disease Vaccine Industry Chain Analysis
12.2 Newcastle Disease Vaccine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Newcastle Disease Vaccine Production Mode & Process
12.4 Newcastle Disease Vaccine Sales and Marketing
12.4.1 Newcastle Disease Vaccine Sales Channels
12.4.2 Newcastle Disease Vaccine Distributors
12.5 Newcastle Disease Vaccine Customers
13 Market Dynamics
13.1 Newcastle Disease Vaccine Industry Trends
13.2 Newcastle Disease Vaccine Market Drivers
13.3 Newcastle Disease Vaccine Market Challenges
13.4 Newcastle Disease Vaccine Market Restraints
14 Key Findings in The Global Newcastle Disease Vaccine Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Newcastle Disease Vaccine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Live Vaccines
Table 3. Major Manufacturers of Killed Vaccines
Table 4. Global Newcastle Disease Vaccine Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global Newcastle Disease Vaccine Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Newcastle Disease Vaccine Revenue by Region (2018-2023) & (US$ Million)
Table 7. Global Newcastle Disease Vaccine Revenue by Region (2024-2029) & (US$ Million)
Table 8. Global Newcastle Disease Vaccine Revenue Market Share by Region (2018-2023)
Table 9. Global Newcastle Disease Vaccine Revenue Market Share by Region (2024-2029)
Table 10. Global Newcastle Disease Vaccine Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 11. Global Newcastle Disease Vaccine Sales by Region (2018-2023) & (M Doses)
Table 12. Global Newcastle Disease Vaccine Sales by Region (2024-2029) & (M Doses)
Table 13. Global Newcastle Disease Vaccine Sales Market Share by Region (2018-2023)
Table 14. Global Newcastle Disease Vaccine Sales Market Share by Region (2024-2029)
Table 15. Global Newcastle Disease Vaccine Sales by Manufacturers (2018-2023) & (M Doses)
Table 16. Global Newcastle Disease Vaccine Sales Share by Manufacturers (2018-2023)
Table 17. Global Newcastle Disease Vaccine Revenue by Manufacturers (2018-2023) & (US$ Million)
Table 18. Global Newcastle Disease Vaccine Revenue Share by Manufacturers (2018-2023)
Table 19. Global Key Players of Newcastle Disease Vaccine, Industry Ranking, 2021 VS 2022 VS 2023
Table 20. Newcastle Disease Vaccine Price by Manufacturers 2018-2023 (USD/K Doses)
Table 21. Global Newcastle Disease Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Newcastle Disease Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Newcastle Disease Vaccine as of 2022)
Table 23. Global Key Manufacturers of Newcastle Disease Vaccine, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Newcastle Disease Vaccine, Product Offered and Application
Table 25. Global Key Manufacturers of Newcastle Disease Vaccine, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Newcastle Disease Vaccine Sales by Type (2018-2023) & (M Doses)
Table 28. Global Newcastle Disease Vaccine Sales by Type (2024-2029) & (M Doses)
Table 29. Global Newcastle Disease Vaccine Sales Share by Type (2018-2023)
Table 30. Global Newcastle Disease Vaccine Sales Share by Type (2024-2029)
Table 31. Global Newcastle Disease Vaccine Revenue by Type (2018-2023) & (US$ Million)
Table 32. Global Newcastle Disease Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 33. Global Newcastle Disease Vaccine Revenue Share by Type (2018-2023)
Table 34. Global Newcastle Disease Vaccine Revenue Share by Type (2024-2029)
Table 35. Newcastle Disease Vaccine Price by Type (2018-2023) & (USD/K Doses)
Table 36. Global Newcastle Disease Vaccine Price Forecast by Type (2024-2029) & (USD/K Doses)
Table 37. Global Newcastle Disease Vaccine Sales by Application (2018-2023) & (M Doses)
Table 38. Global Newcastle Disease Vaccine Sales by Application (2024-2029) & (M Doses)
Table 39. Global Newcastle Disease Vaccine Sales Share by Application (2018-2023)
Table 40. Global Newcastle Disease Vaccine Sales Share by Application (2024-2029)
Table 41. Global Newcastle Disease Vaccine Revenue by Application (2018-2023) & (US$ Million)
Table 42. Global Newcastle Disease Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 43. Global Newcastle Disease Vaccine Revenue Share by Application (2018-2023)
Table 44. Global Newcastle Disease Vaccine Revenue Share by Application (2024-2029)
Table 45. Newcastle Disease Vaccine Price by Application (2018-2023) & (USD/K Doses)
Table 46. Global Newcastle Disease Vaccine Price Forecast by Application (2024-2029) & (USD/K Doses)
Table 47. US & Canada Newcastle Disease Vaccine Sales by Type (2018-2023) & (M Doses)
Table 48. US & Canada Newcastle Disease Vaccine Sales by Type (2024-2029) & (M Doses)
Table 49. US & Canada Newcastle Disease Vaccine Revenue by Type (2018-2023) & (US$ Million)
Table 50. US & Canada Newcastle Disease Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 51. US & Canada Newcastle Disease Vaccine Sales by Application (2018-2023) & (M Doses)
Table 52. US & Canada Newcastle Disease Vaccine Sales by Application (2024-2029) & (M Doses)
Table 53. US & Canada Newcastle Disease Vaccine Revenue by Application (2018-2023) & (US$ Million)
Table 54. US & Canada Newcastle Disease Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 55. US & Canada Newcastle Disease Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 56. US & Canada Newcastle Disease Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 57. US & Canada Newcastle Disease Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 58. US & Canada Newcastle Disease Vaccine Sales by Country (2018-2023) & (M Doses)
Table 59. US & Canada Newcastle Disease Vaccine Sales by Country (2024-2029) & (M Doses)
Table 60. Europe Newcastle Disease Vaccine Sales by Type (2018-2023) & (M Doses)
Table 61. Europe Newcastle Disease Vaccine Sales by Type (2024-2029) & (M Doses)
Table 62. Europe Newcastle Disease Vaccine Revenue by Type (2018-2023) & (US$ Million)
Table 63. Europe Newcastle Disease Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 64. Europe Newcastle Disease Vaccine Sales by Application (2018-2023) & (M Doses)
Table 65. Europe Newcastle Disease Vaccine Sales by Application (2024-2029) & (M Doses)
Table 66. Europe Newcastle Disease Vaccine Revenue by Application (2018-2023) & (US$ Million)
Table 67. Europe Newcastle Disease Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 68. Europe Newcastle Disease Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 69. Europe Newcastle Disease Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 70. Europe Newcastle Disease Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 71. Europe Newcastle Disease Vaccine Sales by Country (2018-2023) & (M Doses)
Table 72. Europe Newcastle Disease Vaccine Sales by Country (2024-2029) & (M Doses)
Table 73. China Newcastle Disease Vaccine Sales by Type (2018-2023) & (M Doses)
Table 74. China Newcastle Disease Vaccine Sales by Type (2024-2029) & (M Doses)
Table 75. China Newcastle Disease Vaccine Revenue by Type (2018-2023) & (US$ Million)
Table 76. China Newcastle Disease Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 77. China Newcastle Disease Vaccine Sales by Application (2018-2023) & (M Doses)
Table 78. China Newcastle Disease Vaccine Sales by Application (2024-2029) & (M Doses)
Table 79. China Newcastle Disease Vaccine Revenue by Application (2018-2023) & (US$ Million)
Table 80. China Newcastle Disease Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 81. Asia Newcastle Disease Vaccine Sales by Type (2018-2023) & (M Doses)
Table 82. Asia Newcastle Disease Vaccine Sales by Type (2024-2029) & (M Doses)
Table 83. Asia Newcastle Disease Vaccine Revenue by Type (2018-2023) & (US$ Million)
Table 84. Asia Newcastle Disease Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 85. Asia Newcastle Disease Vaccine Sales by Application (2018-2023) & (M Doses)
Table 86. Asia Newcastle Disease Vaccine Sales by Application (2024-2029) & (M Doses)
Table 87. Asia Newcastle Disease Vaccine Revenue by Application (2018-2023) & (US$ Million)
Table 88. Asia Newcastle Disease Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 89. Asia Newcastle Disease Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 90. Asia Newcastle Disease Vaccine Revenue by Region (2018-2023) & (US$ Million)
Table 91. Asia Newcastle Disease Vaccine Revenue by Region (2024-2029) & (US$ Million)
Table 92. Asia Newcastle Disease Vaccine Sales by Region (2018-2023) & (M Doses)
Table 93. Asia Newcastle Disease Vaccine Sales by Region (2024-2029) & (M Doses)
Table 94. Middle East, Africa and Latin America Newcastle Disease Vaccine Sales by Type (2018-2023) & (M Doses)
Table 95. Middle East, Africa and Latin America Newcastle Disease Vaccine Sales by Type (2024-2029) & (M Doses)
Table 96. Middle East, Africa and Latin America Newcastle Disease Vaccine Revenue by Type (2018-2023) & (US$ Million)
Table 97. Middle East, Africa and Latin America Newcastle Disease Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 98. Middle East, Africa and Latin America Newcastle Disease Vaccine Sales by Application (2018-2023) & (M Doses)
Table 99. Middle East, Africa and Latin America Newcastle Disease Vaccine Sales by Application (2024-2029) & (M Doses)
Table 100. Middle East, Africa and Latin America Newcastle Disease Vaccine Revenue by Application (2018-2023) & (US$ Million)
Table 101. Middle East, Africa and Latin America Newcastle Disease Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 102. Middle East, Africa and Latin America Newcastle Disease Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 103. Middle East, Africa and Latin America Newcastle Disease Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 104. Middle East, Africa and Latin America Newcastle Disease Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 105. Middle East, Africa and Latin America Newcastle Disease Vaccine Sales by Country (2018-2023) & (M Doses)
Table 106. Middle East, Africa and Latin America Newcastle Disease Vaccine Sales by Country (2024-2029) & (M Doses)
Table 107. Merial Company Information
Table 108. Merial Description and Major Businesses
Table 109. Merial Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
Table 110. Merial Newcastle Disease Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Merial Recent Developments
Table 112. CEVA Company Information
Table 113. CEVA Description and Major Businesses
Table 114. CEVA Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
Table 115. CEVA Newcastle Disease Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. CEVA Recent Developments
Table 117. QYH Biotech Company Information
Table 118. QYH Biotech Description and Major Businesses
Table 119. QYH Biotech Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
Table 120. QYH Biotech Newcastle Disease Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. QYH Biotech Recent Developments
Table 122. Ringpu Biology Company Information
Table 123. Ringpu Biology Description and Major Businesses
Table 124. Ringpu Biology Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
Table 125. Ringpu Biology Newcastle Disease Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Ringpu Biology Recent Developments
Table 127. Yebio Company Information
Table 128. Yebio Description and Major Businesses
Table 129. Yebio Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
Table 130. Yebio Newcastle Disease Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Yebio Recent Developments
Table 132. Harbin Veterinary Research Institute Company Information
Table 133. Harbin Veterinary Research Institute Description and Major Businesses
Table 134. Harbin Veterinary Research Institute Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
Table 135. Harbin Veterinary Research Institute Newcastle Disease Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Harbin Veterinary Research Institute Recent Developments
Table 137. Merck Animal Health Company Information
Table 138. Merck Animal Health Description and Major Businesses
Table 139. Merck Animal Health Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
Table 140. Merck Animal Health Newcastle Disease Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Merck Animal Health Recent Developments
Table 142. DHN Company Information
Table 143. DHN Description and Major Businesses
Table 144. DHN Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
Table 145. DHN Newcastle Disease Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. DHN Recent Developments
Table 147. Zoetis Company Information
Table 148. Zoetis Description and Major Businesses
Table 149. Zoetis Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
Table 150. Zoetis Newcastle Disease Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. Zoetis Recent Developments
Table 152. ChengDu Tecbond Company Information
Table 153. ChengDu Tecbond Description and Major Businesses
Table 154. ChengDu Tecbond Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
Table 155. ChengDu Tecbond Newcastle Disease Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. ChengDu Tecbond Recent Developments
Table 157. Elanco (Lohmann) Company Information
Table 158. Elanco (Lohmann) Description and Major Businesses
Table 159. Elanco (Lohmann) Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
Table 160. Elanco (Lohmann) Newcastle Disease Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 161. Elanco (Lohmann) Recent Developments
Table 162. FATRO Company Information
Table 163. FATRO Description and Major Businesses
Table 164. FATRO Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
Table 165. FATRO Newcastle Disease Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 166. FATRO Recent Developments
Table 167. CAVAC Company Information
Table 168. CAVAC Description and Major Businesses
Table 169. CAVAC Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
Table 170. CAVAC Newcastle Disease Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 171. CAVAC Recent Developments
Table 172. Vaksindo Company Information
Table 173. Vaksindo Description and Major Businesses
Table 174. Vaksindo Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
Table 175. Vaksindo Newcastle Disease Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 176. Vaksindo Recent Developments
Table 177. Key Raw Materials Lists
Table 178. Raw Materials Key Suppliers Lists
Table 179. Newcastle Disease Vaccine Distributors List
Table 180. Newcastle Disease Vaccine Customers List
Table 181. Newcastle Disease Vaccine Market Trends
Table 182. Newcastle Disease Vaccine Market Drivers
Table 183. Newcastle Disease Vaccine Market Challenges
Table 184. Newcastle Disease Vaccine Market Restraints
Table 185. Research Programs/Design for This Report
Table 186. Key Data Information from Secondary Sources
Table 187. Key Data Information from Primary Sources
List of Figures
Figure 1. Newcastle Disease Vaccine Product Picture
Figure 2. Global Newcastle Disease Vaccine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Newcastle Disease Vaccine Market Share by Type in 2022 & 2029
Figure 4. Live Vaccines Product Picture
Figure 5. K

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Classical Swine Fever Vaccines Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 100

It is a type of vaccine for classical swine fever. Classical swine fever (CSF), also known as hog cholera, is a contagious viral disease of pigs, including wild boar. The causative virus is a member of The genus Pestivirus of The family Flaviviridae, and is closely related to The viruses of bovine viral diarrhoea and border disease. There is only one serotype of CSF virus (CSFV). The global Classical Swine Fever Vaccines market was valued at US$ 154.7 million in 2023 and is anticipa......

Global Tylosin Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 96

According to our LPI (LP Information) latest study, the global Tylosin market size was valued at US$ 674.4 million in 2023. With growing demand in downstream market, the Tylosin is forecast to a readjusted size of US$ 909 million by 2030 with a CAGR of 4.4% during review period. The research report highlights the growth potential of the global Tylosin market. Tylosin are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chai......

Global Animal Parasiticides Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 106

According to our LPI (LP Information) latest study, the global Animal Parasiticides market size was valued at US$ 6898.6 million in 2023. With growing demand in downstream market, the Animal Parasiticides is forecast to a readjusted size of US$ 9363.4 million by 2030 with a CAGR of 4.5% during review period. The research report highlights the growth potential of the global Animal Parasiticides market. Animal Parasiticides are expected to show stable growth in the future market. However, ......

Global Newcastle Disease Vaccine Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 114

According to our LPI (LP Information) latest study, the global Newcastle Disease Vaccine market size was valued at US$ 308 million in 2023. With growing demand in downstream market, the Newcastle Disease Vaccine is forecast to a readjusted size of US$ 389.8 million by 2030 with a CAGR of 3.4% during review period. The research report highlights the growth potential of the global Newcastle Disease Vaccine market. Newcastle Disease Vaccine are expected to show stable growth in the future m......

Global Classical Swine Fever Vaccines Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 126

According to our LPI (LP Information) latest study, the global Classical Swine Fever Vaccines market size was valued at US$ 151.4 million in 2023. With growing demand in downstream market, the Classical Swine Fever Vaccines is forecast to a readjusted size of US$ 209.8 million by 2030 with a CAGR of 4.8% during review period. The research report highlights the growth potential of the global Classical Swine Fever Vaccines market. Classical Swine Fever Vaccines are expected to show stable ......

Global Veterinary Vaccine Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 151

According to our LPI (LP Information) latest study, the global Veterinary Vaccine market size was valued at US$ 10570 million in 2023. With growing demand in downstream market, the Veterinary Vaccine is forecast to a readjusted size of US$ 17200 million by 2030 with a CAGR of 7.2% during review period. The research report highlights the growth potential of the global Veterinary Vaccine market. Veterinary Vaccine are expected to show stable growth in the future market. However, product di......

Global Foot and Mouth Disease (FMD) Vaccines Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 134

According to our LPI (LP Information) latest study, the global Foot and Mouth Disease (FMD) Vaccines market size was valued at US$ 895.6 million in 2023. With growing demand in downstream market, the Foot and Mouth Disease (FMD) Vaccines is forecast to a readjusted size of US$ 1644.2 million by 2030 with a CAGR of 9.1% during review period. The research report highlights the growth potential of the global Foot and Mouth Disease (FMD) Vaccines market. Foot and Mouth Disease (FMD) Vaccines......

Global Veterinary Products for Companion Animals Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 109

According to our LPI (LP Information) latest study, the global Veterinary Products for Companion Animals market size was valued at US$ 15190 million in 2023. With growing demand in downstream market, the Veterinary Products for Companion Animals is forecast to a readjusted size of US$ 22710 million by 2030 with a CAGR of 5.9% during review period. The research report highlights the growth potential of the global Veterinary Products for Companion Animals market. Veterinary Products for Co......

Global Newcastle Disease Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 115

According to our (Global Info Research) latest study, the global Newcastle Disease Vaccine market size was valued at USD 323.9 million in 2023 and is forecast to a readjusted size of USD 402.7 million by 2030 with a CAGR of 3.2% during review period. Newcastle disease is a contagious viral bird disease affecting many domestic and wild avian species; it is transmissible to humans. Newcastle disease can be controlled by the use of vaccines. There are many Newcastle disease vaccines s......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs